Wellbeing Digital Sciences, Inc. is a healthcare company, which engages in the development and implementation of innovative clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research. The company is headquartered in London, Ontario. The company went IPO on 2021-01-27. The firm is focused on the development and implementation of clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research. The company operates through three segments: Wellbeing & IRP; KGK Science and Mindscape. The company operates medical clinics across North America to help its patients access plant-based medicines, psychedelics, and other forms of mental health care, all of which have the potential to heal them of their physical and/or emotional pain. Its subsidiaries include Mindscape Ketamine & Infusions Therapy LLC, KGK Science Inc. and Integrated Rehab and Performance Ltd. The company is supported by a network of North American clinics that provide therapies and other types of treatment to patients, as well as through a contract research organization that offers clinical trials services to clients pursuing drug development.
Follow-Up Questions
Wellbeing Digital Sciences Inc (KONEF)의 PER은 얼마입니까?
Wellbeing Digital Sciences Inc의 PER은 0입니다
Wellbeing Digital Sciences Inc의 CEO는 누구입니까?
Ms. Najla Guthrie은 2021부터 회사에 합류한 Wellbeing Digital Sciences Inc의 Chief Executive Officer입니다.
KONEF 주식의 가격 성능은 어떻습니까?
KONEF의 현재 가격은 $0이며, 전 거래일에 decreased 0% 하였습니다.
Wellbeing Digital Sciences Inc의 주요 사업 주제나 업종은 무엇입니까?
Wellbeing Digital Sciences Inc은 Health Care 업종에 속하며, 해당 부문은 Health Care입니다
